Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

811 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Repurposing Licensed Drugs with Activity Against Epstein-Barr Virus for Treatment of Multiple Sclerosis: A Systematic Approach.
Li V, McKay FC, Tscharke DC, Smith C, Khanna R, Lechner-Scott J, Rawlinson WD, Lloyd AR, Taylor BV, Morahan JM, Steinman L, Giovannoni G, Bar-Or A, Levy M, Drosu N, Potter A, Caswell N, Smith L, Brady EC, Frost B, Hodgkinson S, Hardy TA, Broadley SA; Australian Anti-EBV Drugs for MS Working Group. Li V, et al. Among authors: giovannoni g. CNS Drugs. 2025 Jan 10. doi: 10.1007/s40263-024-01153-5. Online ahead of print. CNS Drugs. 2025. PMID: 39792343
Epstein-Barr Virus in Multiple Sclerosis: Theory and Emerging Immunotherapies.
Bar-Or A, Pender MP, Khanna R, Steinman L, Hartung HP, Maniar T, Croze E, Aftab BT, Giovannoni G, Joshi MA. Bar-Or A, et al. Among authors: giovannoni g. Trends Mol Med. 2020 Mar;26(3):296-310. doi: 10.1016/j.molmed.2019.11.003. Epub 2019 Dec 17. Trends Mol Med. 2020. PMID: 31862243 Free PMC article. Review.
Beyond the B-cell as a treatment target in multiple sclerosis.
Giovannoni G, Hawkes CH, Lechner-Scott J, Levy M, Yeh EA. Giovannoni G, et al. Mult Scler Relat Disord. 2023 Jul;75:104786. doi: 10.1016/j.msard.2023.104786. Epub 2023 Jun 1. Mult Scler Relat Disord. 2023. PMID: 37295263 No abstract available.
Ageing and multiple sclerosis.
Giovannoni G, Hawkes CH, Lechner-Scott J, Levy M, Waubant E. Giovannoni G, et al. Mult Scler Relat Disord. 2020 Feb;38:101953. doi: 10.1016/j.msard.2020.101953. Epub 2020 Feb 2. Mult Scler Relat Disord. 2020. PMID: 32164909 No abstract available.
Air pollution and multiple sclerosis risk.
Giovannoni G, Hawkes CH, Lechner-Scott J, Levy M, Pohl D. Giovannoni G, et al. Mult Scler Relat Disord. 2021 Feb;48:102797. doi: 10.1016/j.msard.2021.102797. Epub 2021 Jan 30. Mult Scler Relat Disord. 2021. PMID: 33593588 No abstract available.
Multiple sclerosis is one disease.
Giovannoni G, Hawkes CH, Lechner-Scott J, Levy M, Yeh EA. Giovannoni G, et al. Mult Scler Relat Disord. 2022 Jul;63:103961. doi: 10.1016/j.msard.2022.103961. Epub 2022 Jun 11. Mult Scler Relat Disord. 2022. PMID: 35714573 No abstract available.
CNS resilience in the progression of MS.
Giovannoni G, Hawkes CH, Lechner-Scott J, Levy M, Ann Yeh E. Giovannoni G, et al. Mult Scler Relat Disord. 2023 Sep;77:104937. doi: 10.1016/j.msard.2023.104937. Epub 2023 Aug 19. Mult Scler Relat Disord. 2023. PMID: 37634271
Is EBV the cause of multiple sclerosis?
Giovannoni G, Hawkes CH, Lechner-Scott J, Levy M, Yeh EA, Gold J. Giovannoni G, et al. Mult Scler Relat Disord. 2022 Feb;58:103636. doi: 10.1016/j.msard.2022.103636. Epub 2022 Jan 29. Mult Scler Relat Disord. 2022. PMID: 35114510 No abstract available.
Epstein-Barr virus, latitude and multiple sclerosis.
Disanto G, Pakpoor J, Morahan JM, Hall C, Meier UC, Giovannoni G, Ramagopalan SV. Disanto G, et al. Among authors: giovannoni g. Mult Scler. 2013 Mar;19(3):362-5. doi: 10.1177/1352458512451942. Epub 2012 Jul 5. Mult Scler. 2013. PMID: 22767435
811 results